创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

Advanced Search

column
Prairie Fire out from Little Sparks—Progress and Prospects of Drug Therapy for Breast Cancer
HUANG Xiang, YIN Yongmei
2024, 48(2): 81-84. DOI: 10.20053/j.issn1001-5094.2024.02.001
Abstract PDF
Mechanism and Application Progress of Tumor Immune Markers in Breast Cancer Immunotherapy
YANG Kai, ZENG Tianyu, YIN Yongmei
2024, 48(2): 85-95. DOI: 10.20053/j.issn1001-5094.2024.02.002
Abstract PDF
Research Progress of Antibody-Drug Conjugates for HER2 Low Expression Advanced Breast Cancer
QU Fei, SUN Chunxiao, LI Wei
2024, 48(2): 96-104. DOI: 10.20053/j.issn1001-5094.2024.02.003
Abstract PDF
Advances in Endocrine Resistance and Targeted Therapy of Advanced Hormone Receptor-Positive Breast Cancer
LI Zeying, YANG Fan, HUANG Xiang, YIN Yongmei
2024, 48(2): 105-117. DOI: 10.20053/j.issn1001-5094.2024.02.004
Abstract PDF
Advances of Antibody-Drug Conjugates Targeting Trop-2 in the Treatment of Breast Cancer
LU Rongrong, QU Fei, LIU Qian, LI Wei
2024, 48(2): 118-124. DOI: 10.20053/j.issn1001-5094.2024.02.005
Abstract PDF
Advances in Selective Estrogen Receptor Degraders
FANG Wentong, GUO Mingxin, CAO Mengda, YIN Yongmei
2024, 48(2): 125-133. DOI: 10.20053/j.issn1001-5094.2024.02.006
Abstract PDF
Development and Quality Control of High-End Pharmaceutical Preparations through Quality by Design
HU Xuedan, LI Jing, SUN Minjie
2024, 48(2): 134-142. DOI: 10.20053/j.issn1001-5094.2024.02.007
Abstract PDF
Intervention in Wound Healing of Diabetic Foot with Traditional Chinese Medicine via Wnt/β-Catenin Signaling Pathway
YANG Ning, WANG Yichen, DING Xuansheng
2024, 48(2): 143-150. DOI: 10.20053/j.issn1001-5094.2024.02.008
Abstract PDF
Role of CGRP in Migraine and Research Advances in CGRP-Targeted Drugs
LI Xue, QI Weiyan, XU Hanmei, HU Jialiang
2024, 48(2): 151-160. DOI: 10.20053/j.issn1001-5094.2024.02.009
Abstract PDF